Cell-specific temporal infection of the brain in a simian immunodeficiency virus model of human immunodeficiency virus encephalitis

被引:12
|
作者
Thompson, Katherine A. [1 ,2 ]
Varrone, John J. [3 ]
Jankovic-Karasoulos, Tanja [1 ,2 ]
Wesselingh, Steven L. [2 ,4 ]
McLean, Catriona A. [1 ,2 ]
机构
[1] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3004, Australia
[2] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia
[3] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA
[4] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
human immunodeficiency virus; simian immunodeficiency virus encephalitis; neuropathogenesis; laser microdissection; CENTRAL-NERVOUS-SYSTEM; LASER CAPTURE MICRODISSECTION; ACTIVE ANTIRETROVIRAL THERAPY; PERIVASCULAR MACROPHAGES; HIV-INFECTION; NEUROVIRULENT SIV; MANNOSE RECEPTOR; AIDS DEMENTIA; IN-VITRO; ASTROCYTES;
D O I
10.1080/13550280903030125
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence supports early brain infection by human immunodeficiency virus (HIV). Definitive temporal studies determining when and within which brain cells viral DNA is present are lacking. This study utilized simian immunodeficiency virus (SIV)-infected macaques sacrificed at days 10, 21, 56, and 84 post inoculation. Laser-microdissection isolated pure perivascular macrophage, parenchymal microglia, and astrocyte populations. Nested polymerase chain reaction (PCR) and sequencing determined the presence and characteristics of SIV V3 and V1 env DNA from each population. At day 10, SIV DNA was detected in perivascular macrophage and astrocytes but not parenchymal microglia. gp41 expression was restricted to perivascular macrophage. At day 21, SIV DNA was not detected in any cell type. At day 56, SIV DNA was detectable in perivascular macrophage from one of two macaques, with no gp41 expression detected. At day 84 (morphologic and clinical encephalitis), SIV DNA was detected in all cell types, gp41 was only detected in perivascular macrophage and parenchymal microglia. The neurovirulent molecular clone, SIV/17E-Fr, was the only genotype identified in the brain cell populations. Early, productive brain SIV infection was transient and restricted to trafficking perivascular macrophage. During the nonencephalitic stage, there was a period of time when no SIV DNA could be detected in the brain cell populations. SIV was then seen to reenter the brain via infected perivascular macrophage, leading to productive infection of brain parenchymal macrophage/microglia with a terminal phase of encephalitis. These data challenge current notions of a HIV reservoir within latently infected, semipermanent brain cells and has significant implications for the timing and design of therapies to prevent HIV encephalitis (HIVE). Journal of NeuroVirology (2009) 15, 300-311.
引用
收藏
页码:300 / 311
页数:12
相关论文
共 50 条
  • [1] Cell-specific temporal infection of the brain in a simian immunodeficiency virus model of human immunodeficiency virus encephalitis
    Katherine A. Thompson
    John J. Varrone
    Tanja Jankovic-Karasoulos
    Steven L. Wesselingh
    Catriona A. McLean
    Journal of NeuroVirology, 2009, 15 : 300 - 311
  • [2] Cell specific temporal infection of the central nervous system in a simian immunodeficiency virus model of human immunodeficiency virus encephalitis
    Katherine Thompson
    John Varrone
    Tanja Karasoulos
    Steven Wesselingh
    Catriona McLean
    BMC Proceedings, 2 (Suppl 1)
  • [3] YKL-40: A candidate biomarker for simian immunodeficiency virus and human immunodeficiency virus encephalitis?
    Kolson, Dennis L.
    AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (01): : 25 - 29
  • [4] Induction of cell cycle regulators in simian immunodeficiency virus encephalitis
    Wiley, C
    Jordan-Sciutto, KL
    Wang, G
    Murphy-Corb, M
    BRAIN PATHOLOGY, 2000, 10 (04) : 758 - 759
  • [5] Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections
    Overbaugh, J
    Luciw, PA
    Hoover, EA
    AIDS, 1997, 11 : S47 - S54
  • [6] A model for testing the immunogenicity of simian immunodeficiency virus and simian-human immunodeficiency virus vaccine candidates in mice
    Xu, Jun
    Kelly, Matthew
    Denning, Warren
    Hel, Zdenek
    JOURNAL OF VIROLOGICAL METHODS, 2009, 158 (1-2) : 70 - 76
  • [7] Blood-brain barrier disruption in simian immunodeficiency virus encephalitis
    Luabeya, MK
    Dallasta, LM
    Achim, CL
    Pauza, CD
    Hamilton, RL
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2000, 26 (05) : 454 - 462
  • [8] Pathogenesis of simian immunodeficiency virus infection
    Whetter, LE
    Ojukwu, IC
    Novembre, FJ
    Dewhurst, S
    JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 1557 - 1568
  • [9] Simian immunodeficiency virus infection of chimpanzees
    Sharp, PM
    Shaw, GM
    Hahn, BH
    JOURNAL OF VIROLOGY, 2005, 79 (07) : 3891 - 3902
  • [10] Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections
    DiNapoli, Sarah R.
    Hirsch, Vanessa M.
    Brenchley, Jason M.
    JOURNAL OF VIROLOGY, 2016, 90 (17) : 7596 - 7606